lobbying_activities: 2143070

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2143070	b83e13ee-c0bf-4d04-9431-dab0b8afff05	Q2	THE PAUL LAXALT GROUP	22325	THE ROGOSIN INSTITUTE	2018	second_quarter	MED	Monitor issues concerning improvements in medical research and treatment of kidney disease. Dialysis PATIENTS Demonstration Act of 2017 - HR 4143 and S 2065 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 - HR 2644 and S 1980	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2018-07-12T13:40:43.570000-04:00